ARCHIVES

Part II of Q&A With NCI Director Harold Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 30 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA says new tools needed to speed therapeutics development.

March 26, 2004

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975